Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kobayashi Pharmaceutical is a prominent Japanese consumer healthcare company that develops, manufactures, and markets a wide range of over-the-counter (OTC) medicines, health supplements, and household products. Founded in 1886 and headquartered in Osaka, the company is renowned for its "niche" strategy, focusing on innovative products that address specific, often overlooked consumer needs. Its flagship brands include Ammeltz (topical analgesic), Koolfever (cooling gel sheets), and Naicitol (weight management). The company operates globally, with a significant presence in Asia and the United States, focusing on improving quality of life through accessible healthcare and hygiene products. In 2024, the company underwent a major leadership restructuring and governance overhaul following a significant product safety crisis involving its red yeast rice supplements.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kobayashi Sei.